Johnstone B - Search Results

1

Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents.

Kim K, Unni S, McAdam-Marx C, Thomas SM, Sterling KL, Olsen CJ, Johnstone B, Mitchell M, Brixner D. Kim K, et al. Among authors: johnstone b. J Manag Care Spec Pharm. 2019 Mar;25(3):314-322. doi: 10.18553/jmcp.2019.25.3.314. J Manag Care Spec Pharm. 2019. PMID: 30816811 Free PMC article.

2

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.

Oster G, Sullivan SD, Dalal MR, Kazemi MR, Rojeski M, Wysham CH, Sung J, Johnstone B, Cali AM, Wei LJ, Traylor L, Anhalt H, Hull M, Van Vleet J, Meneghini LF. Oster G, et al. Among authors: johnstone b. Postgrad Med. 2016 Nov;128(8):731-739. doi: 10.1080/00325481.2016.1241663. Epub 2016 Oct 24. Postgrad Med. 2016. PMID: 27690710 Clinical Trial.

3

A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.

Anderson JE, Rhinehart AS, Reid TS, Cuddihy RM, Vlajnic A, Dalal MR, Gemmen E, Johnstone B, Abbaszadeh B, Reed J, Sheller J, Stewart J, Mozaffari E; Diabetes FORWARD Investigators. Anderson JE, et al. Among authors: johnstone b. Postgrad Med. 2013 May;125(3):172-80. doi: 10.3810/pgm.2013.05.2658. Postgrad Med. 2013. PMID: 23748518

4

Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia.

Glazer WM, Johnstone BM. Glazer WM, et al. Among authors: johnstone bm. J Clin Psychiatry. 1997;58 Suppl 10:50-4. J Clin Psychiatry. 1997. PMID: 9265917 Review.

5

Cost-effectiveness of PCSK9 Inhibitor Therapy.

Mastey V, Johnstone BM. Mastey V, et al. JAMA. 2016 Nov 22;316(20):2151-2152. doi: 10.1001/jama.2016.16286. JAMA. 2016. PMID: 27893122 No abstract available.

6

Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care.

Ivanova JI, Birnbaum HG, Schiller M, Kantor E, Johnstone BM, Swindle RW. Ivanova JI, et al. Spine J. 2011 Jul;11(7):622-32. doi: 10.1016/j.spinee.2011.03.017. Epub 2011 May 20. Spine J. 2011. PMID: 21601533

7

Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia.

Tunis SL, Johnstone BM, Gibson PJ, Loosbrock DL, Dulisse BK. Tunis SL, et al. Among authors: johnstone bm. J Clin Psychiatry. 1999;60 Suppl 19:38-45; discussion 46. J Clin Psychiatry. 1999. PMID: 10507279 Clinical Trial.

8

Antipsychotic drug use patterns and the cost of treating schizophrenia.

McCombs JS, Nichol MB, Johnstone BM, Stimmel GL, Shi J, Smith R. McCombs JS, et al. Among authors: johnstone bm. Psychiatr Serv. 2000 Apr;51(4):525-7. doi: 10.1176/appi.ps.51.4.525. Psychiatr Serv. 2000. PMID: 10737831

9

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS. Loosbrock DL, et al. J Ment Health Policy Econ. 2003 Jun;6(2):67-75. J Ment Health Policy Econ. 2003. PMID: 14578539

10

Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies.

Tunis SL, Johnstone BM, Kinon BJ, Barber BL, Browne RA. Tunis SL, et al. Among authors: johnstone bm. Value Health. 2000 May-Jun;3(3):232-42. doi: 10.1046/j.1524-4733.2000.33007.x. Value Health. 2000. PMID: 16464187 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters